Discover Thomson Reuters
Dec. 24 - Sources tell Reuters a deal of about $4 billion could be struck within two weeks for Johnson & Johnson's blood testing business. Fred Katayama reports.
01:13
02:10
01:45
07:21
01:58
01:29
02:07
01:53
02:09
01:49
01:05
00:37
01:10
01:46
01:37
01:36
01:42
01:57